Plasma antioxidant levels in chronic cholestatic liver diseases
- 1 March 2000
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (3), 353-358
- https://doi.org/10.1046/j.1365-2036.2000.00729.x
Abstract
A predictable consequence of cholestasis is malabsorption of fat-soluble factors, (vitamins A, D, E, K) and other free radical scavengers, such as carotenoids. It has been suggested that oxygen-derived free radicals may be involved in the pathogenesis of chronic liver damage. (i) To evaluate retinol, α-tocopherol and carotenoid plasma levels in two groups of patients with chronic cholestatic liver disease (primary biliary cirrhosis and primary sclerosing cholangitis); (ii) to compare the respective plasma levels with those of the general population; (iii) to correlate the plasma levels with disease severity. A total of 105 patients with chronic cholestasis were included in the study: 86 with primary biliary cirrhosis (81 female, five male, mean age 55.5 ± 11 years), 19 with primary sclerosing cholangitis (seven female, 12 male, mean age 35 ± 11 years; six patients had associated inflammatory bowel disease); 105 sex- and age-matched subjects from the general population in the same geographical area (88 female, 17 male, mean age 51.3.5 ± 10 years) served as controls. Carotenoids (lutein zeaxanthin, lycopene, β-carotene, α-carotene, β-cryptoxanthin), retinol and α-tocopherol were assayed by high-pressure liquid chromatography. A food frequency questionnaire was administered to each subject to evaluate the quality and the quantity of dietary compounds. Data were processed by analysis of variance and linear regression analysis, as appropriate. Both primary biliary cirrhosis and primary sclerosing cholangitis patients had significantly lower levels of retinol, α-tocopherol, total carotenoids, lutein, zeaxanthin, lycopene, α- and β-carotene than controls (P < 0.0001). Among the cholestatic patients, no significant difference in the concentration of antioxidants was observed between primary biliary cirrhosis and primary sclerosing cholangitis subjects. Anti-oxidant plasma levels were not affected by the severity of the histological stage in primary biliary cirrhosis, but a negative correlation was found between total carotenoids and both alkaline phosphatase (ALP) and gammaglutamyl transpeptidase (GGT) (P < 0.013 and P < 0.018, respectively). Within the primary sclerosing cholangitis group, no correlation was found between total carotenoids and cholestatic enzymes. Nutritional intake in cholestatic patients was comparable to controls, including fruit and vegetable intake. Although no clinical sign of deficiency is evident, plasma levels of antioxidants are low in cholestatic patients even in early stages of the disease. This is probably due to malabsorption of fat-soluble vitamins, as well as other mechanisms of hepatic release, suggesting the need for dietary supplementation.Keywords
This publication has 24 references indexed in Scilit:
- Hepatic and Extrahepatic Malignancies in Primary Biliary CirrhosisHepatology, 1999
- Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomesHepatology, 1997
- Carotenoids and tocopherols in various hepatobiliary conditionsJournal of Hepatology, 1995
- Impaired release of vitamin a from liver in primary biliary cirrhosis†Hepatology, 1988
- Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis.BMJ, 1986
- Breast cancer in women with primary biliary cirrhosis.BMJ, 1985
- Primary biliary cirrhosis, dark adaptometry, electro-oculography, and vitamin A state.BMJ, 1984
- Vitamin A treatment for night blindness in primary biliary cirrhosis.BMJ, 1984